We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$526M
AUM Growth
+$2.73M
Cap. Flow
-$3.25M
Cap. Flow %
-0.62%
Top 10 Hldgs %
28.13%
Holding
250
New
19
Increased
91
Reduced
65
Closed
17

Top Buys

Rank Stock Value
1
RL icon
Ralph Lauren
RL
+$7.83M
2
CMI icon
Cummins
CMI
+$3.81M
3
GILD icon
Gilead Sciences
GILD
+$3.61M
4
NXPI icon
NXP Semiconductors
NXPI
+$2.89M
5
TRI icon
Thomson Reuters
TRI
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 19.61%
3 Financials 12.5%
4 Industrials 10.74%
5 Consumer Discretionary 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNA icon
126
Synaptics
SYNA
$4.13B
$838K 0.16%
11,450
-1,650
-13% -$135K
UI icon
127
Ubiquiti
UI
$33.2B
$832K 0.16%
+22,160
New +$941K
BDSI
128
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$828K 0.16%
48,475
+32,025
+195% +$465K
SNBR
129
DELISTED
Sleep Number
SNBR
$812K 0.15%
38,800
+4,200
+12% +$88.6K
GD icon
130
General Dynamics
GD
$103B
$790K 0.15%
6,220
-280
-4% -$34K
AEE icon
131
Ameren
AEE
$30.3B
$787K 0.15%
20,525
+340
+2% +$13.3K
PFE icon
132
Pfizer
PFE
$143B
$766K 0.15%
27,312
+79
+0.3% +$2.22K
TFC icon
133
Truist Financial
TFC
$63.4B
$763K 0.15%
20,502
-794
-4% -$30K
PCRX icon
134
Pacira BioSciences
PCRX
$1.06B
$754K 0.14%
7,775
JPM icon
135
JPMorgan Chase
JPM
$937B
$729K 0.14%
12,098
-343
-3% -$20.1K
SPNC
136
DELISTED
Spectranetics Corp
SPNC
$709K 0.13%
26,700
+2,450
+10% +$65.8K
DEO icon
137
Diageo
DEO
$49.2B
$696K 0.13%
6,035
-73,950
-92% -$8.95M
VTLE
138
DELISTED
Vital Energy
VTLE
$681K 0.13%
1,520
+1,105
+266% +$564K
CAT icon
139
Caterpillar
CAT
$382B
$677K 0.13%
6,828
ARIA
140
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$672K 0.13%
124,400
+11,100
+10% +$64.8K
VCRA
141
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$658K 0.13%
81,550
+8,350
+11% +$84.7K
TYPE
142
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$656K 0.12%
23,150
-3,400
-13% -$99.1K
ZWS icon
143
Zurn Elkay Water Solutions
ZWS
$8.49B
$654K 0.12%
47,748
+26,780
+128% +$368K
SPY icon
144
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$652K 0.12%
3,307
POWR
145
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
$646K 0.12%
67,440
-87,520
-56% -$896K
EPZM
146
DELISTED
Epizyme, Inc
EPZM
$625K 0.12%
23,050
-5,050
-18% -$157K
RY icon
147
Royal Bank of Canada
RY
$292B
$616K 0.12%
8,625
+421
+5% +$31K
QLIK
148
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$607K 0.12%
22,450
-5,200
-19% -$136K
PSIX
149
Power Solutions International
PSIX
$663M
$592K 0.11%
8,575
+4,875
+132% +$330K
TRIB
150
Trinity Biotech
TRIB
$7.51M
$581K 0.11%
212
+4
+2% +$13K

Similar funds

Franklin Street Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Franklin Street Advisors held 250 positions worth $526M, up 0.52% from $523M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Franklin Street Advisors's Q3 2014 filing shows 19 new, 91 increased, 65 reduced and 17 closed positions. Its largest new stake was Ralph Lauren: 47,578 shares worth $7.84M. The largest sale was Diageo, an estimated $8.95M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Financials.

  • Franklin Street Advisors's largest Q3 2014 buy was Ralph Lauren: 47,578 shares worth $7.84M.
  • Franklin Street Advisors added most to Gilead Sciences in Q3 2014, an estimated $3.61M increase.
  • Franklin Street Advisors's biggest Q3 2014 reduction was Diageo, cutting an estimated $8.95M.
  • Franklin Street Advisors fully exited FURIEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014, selling an estimated $5.18M.
  • Franklin Street Advisors's ten largest holdings make up 28% of its $526M portfolio in Q3 2014.
  • Franklin Street Advisors opened 19 new positions and closed 17 in Q3 2014.
  • Franklin Street Advisors's portfolio value rose 0.52% quarter-over-quarter to $526M.

Based on Franklin Street Advisors's 13F filing for Q3 2014, filed 7 Oct 2014.